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Abstract
Background: With multiple strains of various pathogens being sequenced, it is necessary to
develop high-throughput methods that can simultaneously process multiple bacterial or viral
genomes to find common fingerprints as well as fingerprints that are unique to each individual
genome. We present algorithmic enhancements to an existing single-genome pipeline that allows
for efficient design of microarray probes common to groups of target genomes. The enhanced
pipeline takes advantage of the similarities in the input genomes to narrow the search to short,
nonredundant regions of the target genomes and, thereby, significantly reduces the computation
time. The pipeline also computes a three-state hybridization matrix, which gives the expected
hybridization of each probe with each target.
Results: Design of microarray probes for eight pathogenic Burkholderia genomes shows that the
multiple-genome pipeline is nearly four-times faster than the single-genome pipeline for this
application. The probes designed for these eight genomes were experimentally tested with one
non-target and three target genomes. Hybridization experiments show that less than 10% of the
designed probes cross hybridize with non-targets. Also, more than 65% of the probes designed to
identify all Burkholderia mallei and B. pseudomallei strains successfully hybridize with a B. pseudomallei
strain not used for probe design.
Conclusion: The savings in runtime suggest that the enhanced pipeline can be used to design
fingerprints for tens or even hundreds of related genomes in a single run. Hybridization results with
an unsequenced B. pseudomallei strain indicate that the designed probes might be useful in
identifying unsequenced strains of B. mallei and B. pseudomallei.
Background
Sequence-based pathogen identification is an increasingly
important tool for clinical diagnostics and environmental
monitoring of biological threat agents. Developments in
sequencing technology have led to the availability of
many pathogen genome sequences. Many more pathogen
genomes and near-neighbors are being sequenced due to
initiatives by the National Institute of Allergy and Infec-
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tious Diseases and the U.S. Department of Defense. Avail-
ability of these genomic sequences has opened up
opportunities for the development of whole-genome-
based diagnostic assays, such as DNA microarrays and
polymerase chain reaction (PCR) assays, which offer more
flexibility than traditional methods based on a single gene
or selected regions of a target genome [1]. Microarray-
based pathogen diagnostic assays are gaining popularity
due to their ability to test for hundreds, or even thou-
sands, of pathogens in a single diagnostic test [2].
Oligonucleotide probes designed for pathogen diagnostic
assays should be unique to the pathogen with respect to
all other non-target genomes. Clinical and environmental
samples may contain a multitude of non-target genomes,
and hence probes designed for diagnostic assays must be
unique with respect to all non-target genomes. As a result,
the design of pathogen diagnostic assays entails the com-
putationally expensive comparison of target genomes
with all known non-target sequences. Many different
methods have been developed to guide the design of path-
ogen diagnostic assays. Some methods [3-5] are intended
for PCR-based assays, whereas others [6-12] are intended
for microarray-based assays. Kaderali and Schliep [6] pre-
sented one of the first methods for designing microarrays
for pathogen identification. Their approach is very similar
to that of designing probes for gene expression analysis;
they design a single probe for each target, with the probe
being unique to the target with respect to all other input
target sequences. However, the specificity of the probe
with respect to other non-target genomes is not analyzed.
A somewhat similar approach is that of host-blind probe
design presented by Putonti et al. [13], in which the
probes are unique only with respect to a host genome.
With a few exceptions, however, most of these tools do
not have the capability of testing for specificity against a
large number of non-target genomes. This is clearly not
adequate if the signatures are to be used to identify the
pathogen from environmental/clinical samples contain-
ing any number of unanticipated non-target organisms.
Some tools for designing PCR assays, such as KPATH [5]
and Insignia [4], perform in silico comparisons against all
known non-target sequences. They also have the ability to
design common signatures for multiple pathogen
sequences. In KPATH, common PCR signatures are
selected from a multiple sequence alignment of the target
genomes. As described by Fitch et al. [3], this approach is
inherently based on the assumption of collinearity within
the target genomes, which may not hold true for bacterial
genomes. Insignia, on the other hand, selects common
signatures from shared sequences discovered through
pairwise local alignments and, hence, does not assume
collinearity.
Neither KPATH nor Insignia is applicable for designing
microarray fingerprints, as the design and specificity
requirements of microarray fingerprints are quite different
from those of PCR signatures. The most commonly used
PCR signatures consist of a probe and two primers and,
due to their short length [18–25 base pairs (bp)] and con-
straints on the interprimer distance, inexact matches with
non-target sequences can be tolerated without much deg-
radation in specificity. Conversely, in addition to being
characterized by only one DNA segment with no spacing
constraints, microarray probes are generally longer and
more susceptible to cross hybridization even in the
absence of an exact match [14]. This requires more exten-
sive searches, for both exact and inexact matches, against
non-target sequences to identify highly specific finger-
prints for microarrays.
We have previously developed a software tool [9,12] for
designing microarray probes that identify fingerprints for
a single target genome. The software, named TOFI (Tool
for Oligonucleotide Fingerprint Identification), is an inte-
grated, scalable, high-performance-computing pipeline,
which combines genome comparison tools, probe design
software, and sequence alignment programs to design
highly specific microarray probes for pathogen identifica-
tion. To our knowledge, TOFI is the only software that has
the ability to design microarray probes that are specific to
the target with respect to all sequenced non-target
genomes.
In this paper, we extend the TOFI pipeline to design
microarray probes for multiple, related, bacterial and viral
pathogens. Our aim is to efficiently identify all probes in
the input target sequences that are unique with respect to
all available non-target sequences. The major contribu-
tions of this paper include: (1) an efficient algorithm that
pre-processes the input target sequences to take advantage
of the similarities among them and reduce their effective
size, which results in considerable speedup (nearly four-
fold for eight targets and greater for larger numbers) when
compared to the previous, single-target version of the
pipeline, (2) a novel three-state hybridization matrix
computation strategy, which identifies probes that can be
used to characterize the possible combinations of the
input target genomes, and (3) a set of experimental results
with multiple Burkholderia genomes, which allow us to
validate the new algorithms and the specificity criteria
that were recently introduced (but not experimentally val-
idated) in [12]. The improved pipeline scales well with
increase in the number of target genomes, and can poten-
tially design fingerprints for hundreds of related target
genomes in a single run.BMC Genomics 2008, 9:496 http://www.biomedcentral.com/1471-2164/9/496
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Methods
In the following, we briefly describe the TOFI pipeline for
a single genome, and then present the algorithmic
improvements implemented to accommodate multiple
genomes. The TOFI pipeline consists of the three main
stages illustrated in Figure 1. The stages are designed so
that large portions of the target genome are eliminated in
the less-expensive two initial stages, and the computation-
ally more expensive searches for specific fingerprints are
performed over smaller regions of the target genome in
the final stage. The reader should refer to [12] for a
detailed description of the TOFI pipeline.
Overview of TOFI pipeline
The first stage of TOFI uses the suffix-tree-based MUMmer
[15] program to perform pairwise comparisons of the tar-
get genome with each non-target genome and eliminate
regions in the target genome that have exact matches with
any of the non-target genomes. Given a pair of sequences,
MUMmer finds all maximal matches that are at least as
long as a threshold (termed minmatch) between the two
sequences. TOFI uses MUMmer to find these maximal
matches and eliminate regions in the target genome that
are covered by them. The selection of minmatch is based
on the specificity parameters supplied by the user. This
ensures that every segment of the target genome that sat-
isfies the restrictions on probe length and specificity
parameters is part of the surviving regions of the target
genome. These surviving regions, referred to as candidate
sequences, are then passed on to the second stage of the
pipeline.
In the second stage, TOFI identifies oligonucleotides of
desired length from the candidate sequences that satisfy
experimental conditions, such as melting temperature
(Tm) and GC content. TOFI uses the Oligonucleotide
Modeling Platform (OMP) software to identify these oli-
gonucleotides, also referred to here as probes. OMP uses
the nearest-neighbor hybridization model [16] to calcu-
late Tm and to estimate if a probe forms any secondary
structures that may prevent it from hybridizing to the
intended target.
In the third and final stage of the pipeline, TOFI performs
a BLAST [17] search for each probe against a comprehen-
sive sequence database, such as the nt database provided
by the National Center for Biotechnology Information
(NCBI). The BLAST comparisons are performed in parallel
Overview of the TOFI pipeline Figure 1
Overview of the TOFI pipeline. Stage 1 and Stage 3 of the TOFI pipeline have been improved to handle multiple genomes. 
In stage 1, the target genomes are compared with each other to eliminate redundant sequences. In Stage3, an in silico hybridiza-
tion matrix is computed, which indicates which probes hybridize to which targets.
Discard common DNA based on exact matches 
one or more  
non-target genomes target genome(s) 
candidate sequences 
Filter the probes based on approximate and exact 
matches with all sequenced non-targets 
Design DNA microarray probes based on 
experimental requirements  
Stage 1 
oligonucleotide probes 
in silico DNA fingerprints
Stage 2 
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on multiple processors using the blastn program of mpi-
BLAST [18]. Probes with significant alignments to non-
target genomes are eliminated, and the surviving probes
become the in silico DNA fingerprints for the target
genomes. These probes are then subjected to experimental
validation to test their sensitivity and specificity.
Multiple Genomes
Given a set of target genomes, our aim is to find microar-
ray fingerprints that are unique to any subset of the target
genomes with respect to all sequenced non-target
genomes. The input consists of a set of K target genomes
T = {t1, t2, ..., tK}, where each target tk, 1 ≤ k ≤ K, is a col-
lection of all the sequences (a FASTA file containing chro-
mosomes, unassembled contigs, etc.) from the kth target
genome. The aim is to select a set of N probes P = {p1, p2,
..., pN}, where each probe pn of length |pn| is a substring of
some sequence in T, with Lmin ≤ |pn| ≤ Lmax, and Lmin and
Lmax  representing the minimum and maximum probe
length constraints, respectively. In addition, a probe pn
should satisfy experimental constraints like GC content
and melting temperature, and should not have significant
sequence similarity with any known genomic sequence
not in T.
The multiple-genome pipeline differs from the single-
genome pipeline in Stage 1 and Stage 3. The major
enhancements include: (1) comparison of each target
genome with all other target sequences to eliminate
redundant sequence segments from further consideration
in Stage 1, and (2) computation of an in silico hybridiza-
tion matrix of patterns in Stage 3, where each pattern iden-
tifies the input target sequences that can be characterized
by a probe.
Preprocessing the target genomes
A brute-force approach for designing fingerprints for mul-
tiple genomes would entail the design of fingerprints for
each genome separately. For K  target genomes, this
approach would take approximately K times the compu-
tation time necessary for designing fingerprints for a sin-
gle genome. Given the recent sequence availability of
multiple bacterial strains of interest (ranging from tens to
hundreds) and the large computation time to identify fin-
gerprints for a typical bacterial genome (~5 hours on 74
processors), such brute-force approach would be imprac-
tical.
In general, there is significant sequence similarity among
closely related genomes. Our approach takes maximum
advantage of such similarities by eliminating (redundant)
sequence segments that are shared by any two input target
genomes. This is done as the first step in Stage 1, where
TOFI compares the targets within themselves to construct
a set of nonredundant target sequences. The fingerprints
for the multiple targets are then designed from these non-
redundant target sequences. Comparison of the input tar-
get sequences is performed using an iterative process that
effectively compares each target genome with all other tar-
get genomes.
We start with the set of target genomes T and a set of non-
redundant target sequences S, which is initially empty. All
sequences in the first target genome t1 are added to S.
Next, we find all exact matches between the sequences in
t2 and S using MUMmer. All exact matches that are longer
than an input threshold are removed from t2, and the
remaining sequences are added to S. This process is
sequentially repeated for all other target genomes. When
processing the kth genome, all nonredundant sequences
from the previous k-1 sequences are already included in S.
Hence, only the nonredundant sequences in tk are added
to S. In this process, minmatch, the threshold for mini-
mum exact matches, should be equal to Lmin. If minmatch
is larger than Lmin, shared sequences of length ≥Lmin not
reported by MUMmer will be included in S, leading to
highly similar segments being added to the list of nonre-
dundant sequences. The nonredundant sequences at the
end of this preprocessing step are then subjected to com-
parisons with non-target sequences to remove exact
matches with non-target sequences. The candidate
sequences at the end of Stage 1 are submitted to Stage 2,
which selects probes satisfying the experimental con-
straints. These probes are then subjected to extensive spe-
cificity analysis in Stage 3, which includes hierarchical
BLAST comparisons against increasingly larger databases
of non-target sequences [12].
In silico Hybridization Expectations
As the probes are designed to identify multiple target
genomes, any given probe is not necessarily a substring of
every target. As a result, it is necessary to explicitly com-
pare each probe against each target sequence to identify
the targets for which the probe can serve as a fingerprint.
We consider multiple criteria in determining the specifi-
city of a probe. Many measures, such as overall sequence
identity, contiguous matches, and predicted free energy,
have all been previously shown to be important measures
of the potential for cross hybridization [19,20]. In addi-
tion to these measures, we use several measures of near-
contiguous matches introduced in a previous paper on
TOFI [12]. To incorporate contiguous and near-contigu-
ous matches in determining probe specificity and estimate
hybridization expectations, we use a series of thresholds,
M0, M1, M2, and M3, where Mi is the maximum length of
a contiguous region in which the alignment between a
probe and a genome sequence has (Mi - i) matches and i
mismatches/insertions/deletions. Accordingly, M0 is the
length of the longest stretch of contiguous matches
between a probe and a genome sequence. Identity, contig-BMC Genomics 2008, 9:496 http://www.biomedcentral.com/1471-2164/9/496
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uous matches, and near-contiguous matches between a
probe and a target/non-target genome are computed from
the BLAST alignments between the two.
We use two sets of thresholds to compute in silico hybrid-
ization expectations. The first set of design thresholds,
denoted by CU, indicates the minimum value of each
parameter necessary for hybridization. The second set of
thresholds, denoted by CL, indicates the maximum value
of each parameter permissible for avoiding hybridization.
CU is used to identify probes that will potentially hybrid-
ize to a genome, and CL is used to identify probes that will
not hybridize to a genome. The individual thresholds in
CU are denoted by IdentityU, M0
U, M1
U, M2
U, and M3
U, and
the individual thresholds in CL are denoted by IdentityL,
M0
L, M1
L, M2
L, and M3
L. For a probe to be considered as an
in silico fingerprint for a target, all specificity measures
between the probe and the target sequence must be
greater than the corresponding thresholds in CU and all
specificity measures between the probe and any non-tar-
get sequence must be less than or equal to the correspond-
ing thresholds in CL. Note that the set of thresholds CU is
only employed to compute the in silico hybridization
expectations, which are used to identify the targets for
which each probe can serve as a fingerprint. Accordingly,
the number of probes reported by TOFI is solely control-
led by the thresholds in CL.
We use the pairwise BLAST program bl2seq to compare
each probe with each target sequence. Based on the align-
ments of the N probes with the K targets, we build an N ×
K hybridization matrix H, where each entry Hnk indicates
whether probe pn hybridizes to target tk. Unlike earlier rep-
resentations [21-23], which use a binary matrix to repre-
sent the hybridization expectations, we use a three-state
matrix. Each Hnk ∈ {-1,0,1}, where Hnk = 1 indicates that
fingerprint pn hybridizes with genome tk, Hnk = -1 indicates
that pn does not hybridize to tk, and Hnk = 0 indicates that
pn may or may not hybridize to tk. We opt for a three-state
representation to more accurately represent the expected
behavior of the probes. In many situations, probes may
have some sequence similarity with a given target, but this
identity may not be high enough to guarantee hybridiza-
tion or low enough to rule out the possibility of hybridi-
zation.
The hybridization matrix is constructed based on the
highest scoring alignment between a probe pn and a target
genome tk, as follows:
i. Hnk = -1 if all the specificity measures are less than or
equal to the corresponding thresholds in CL;
ii. Hnk = 1 if all the specificity measures are greater than the
corresponding thresholds in CU; and
iii. Hnk = 0 if neither (i) nor (ii) is satisfied.
A probe pn is considered unique to a target tk if Hnk = 1, and
Hnj = -1 ∀ j ≠ k. A probe pn is common to a set of targets Ts
if:
i. Hnj = 1 ∀ j | tj ∈ Ts, and
ii. Hnj = -1 ∀ j | tj ∉ Ts.
According to this definition, any probe pn with Hnk = 0 for
any target k can neither be a probe unique to a target nor
a probe common to a set of targets. However, as these are
only  in silico expectations, some of these probes may
prove to be useful after experimental validation.
Results
In this section, we present the results for the identification
of in silico fingerprints (i.e., probe design) and their asso-
ciated experimental evaluation. For the probe design proc-
ess, we used probe length parameters Lmin = 35 and Lmax =
40, and optimal melting temperature of 70°C. Probe
lengths of 35–40 bases were chosen to ensure compatibil-
ity of the probe sequences with microarrays available
from various vendors, some of which are limited to the in
situ synthesis of probes that are 40 bases or less. We used
the entire NCBI nt database to estimate probe specificity.
Probe design
We designed probes for four strains of Burkholderia mallei
and four strains of B. pseudomallei, employing B. thailan-
densis as the non-target near-neighbor genome. Table 1
shows the details of the eight target genomes and the near-
neighbor genome, each consisting of two chromosomes.
The table shows the combined sizes of the two chromo-
somes.
As expected, there is significant sequence similarity
among the eight genomes. The four strains of B. pseudoma-
llei are significantly different from each other. As a result,
the combined nonredundant sequence size increased as
each new B. pseudomallei sequence was processed. Con-
versely, the four strains of B. mallei are very similar to each
other and to the four B. pseudomallei genomes, therefore
only minimally increasing the combined nonredundant
size as these genomes were processed. The combined size
of the target genomes is 51343862 bp. However, the com-
bined size of all nonredundant target sequences after the
preprocessing step in Stage 1 was just 12011005 bp, a
reduction of more than 75%. These nonredundant target
sequences were further compared against the entire nt
database retrieved from NCBI in July 2007. This version of
the nt database consists of more than 5 million sequences
with combined size greater than 21 Gbp.BMC Genomics 2008, 9:496 http://www.biomedcentral.com/1471-2164/9/496
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The strategy of identifying and eliminating redundant
portions of the target sequences considerably reduced the
overall computation time. The total time to design finger-
prints for the eight Burkholderia genomes with TOFI on a
74-processor Linux cluster with distributed memory was 9
hours and 41 minutes. Using the same number of proces-
sors, it took approximately 4 hours and 30 minutes to
design fingerprints for each genome, for a total of 36
hours for processing the eight genomes. Therefore, for the
eight Burkholderia genomes tested, the strategy used in the
multiple-genome pipeline yielded a nearly four-fold
reduction in the computation time in comparison with
the single-genome pipeline. The savings in computation
time would be even greater with larger number of target
genomes.
Table 2 shows the values for the specificity thresholds CL
and CU used for specificity computation with non-targets
and targets, respectively. The thresholds for M0
L and Iden-
tityL were selected based on those suggested in the litera-
ture [14,19,24], and making the necessary adjustments to
obtain a reasonably large number of fingerprints. The
relaxation of these thresholds and the selection of other
thresholds in CL and CU were based on empirical analyses
of free energy computations previously presented [12].
Based on the CL thresholds, a total of 5015 probes were
expected to be free of cross hybridization with non-tar-
gets. Table 3 shows the number of probes expected to
identify each target. The third column in the table shows
the number of probes that passed the design thresholds
CU  for each target strain; meaning that these are the
number of probes that should hybridize with each strain.
The fourth column indicates the number of probes that
are unique to each target; meaning that these probes have
matches ≤CL with all other genomes, including the other
seven target strains. Column five shows the number of
probes common to each subgroup, and the last column
shows the number of probes common to all eight target
strains.
In all, 981 probes out of the total 5015 are expected to
identify all eight strains. A total of 504 probes are unique
to the B. pseudomallei subgroup, meaning that these
probes have matches >CU with all the four B. pseudomallei
strains and matches ≤CL with all other organisms, includ-
ing the four B. mallei strains. Similarly, a total of 31 probes
are unique to the B. mallei subgroup. There are hundreds
of unique probes for each individual B. pseudomallei
strain. However, because of the high similarity between
the  B. mallei genomes, none of the 5015 probes are
unique to any individual B. mallei strain.
Hybridization experiments
Efficient hybridization of bacterial DNA requires that long
genomic DNA molecules be fragmented to shorter lengths
for optimal hybridization. In our experiments, we used
restriction endonuclease digestion to fragment bacterial
DNA prior to labeling and hybridization. Therefore, all
Table 1: NCBI accession numbers and sizes of the Burkholderia genomes used for probe design
Strain Accession no./version Size (bp)
1 B. pseudomallei 1106a NC_009076.1, NC_009078.1 7089249
2 B. pseudomallei 1710b NC_007434.1, NC_007435.1 7308054
3 B. pseudomallei 668 NC_009074.1, NC_009075.1 7040403
4 B. pseudomallei K96243 NC_006350.1, NC_006351.1 7247547
5 B. mallei ATCC 23344 NC_006348.1, NC_006349.1 5835527
6 B. mallei NCTC 10229 NC_008835.1, NC_008836.1 5742303
7 B. mallei NCTC 10247 NC_009079.1, NC_009080.1 5848380
8 B. mallei SAVP1 NC_008784.1, NC_008785.1 5232401
9 B. thailandensis E264 (near-neighbor) NC_007651.1, NC_007650.1 6723972
Table 2: The specificity thresholds used for probe design
CL CU
IdentityL = 85% IdentityU = 90%
M0
L = 18 M0
U = 27
M1
L = 21 M1
U = 29
M2
L = 24 M2
U = 32
M3
L = 27 M3
U = 34
Table 3: Expected behavior of the 5015 designed probes
Target Total Unique Group Common
1 B. pseudomallei 1106a 2710 259 504 981
2 B. pseudomallei 1710b 3346 739 504 981
3 B. pseudomallei 668 2597 601 504 981
4 B. pseudomallei K96243 3084 613 504 981
5 B. mallei ATCC 23344 1373 0 31 981
6 B. mallei NCTC 10229 1339 0 31 981
7 B. mallei NCTC 10247 1567 0 31 981
8 B. mallei SAVP1 1164 0 31 981BMC Genomics 2008, 9:496 http://www.biomedcentral.com/1471-2164/9/496
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probes that overlapped with restriction site positions cor-
responding to restriction enzymes used to prepare the
DNA for hybridization were not included. This reduced
the number of probes from 5015 to 2343. To reduce the
number of probes further, we prioritized probes based on
their predicted hybridization patterns and selected a total
of 1214 probes by eliminating probes that were neither
unique to an individual strain nor common to all strains
in any of the two Burkholderia  species. We conducted
hybridization experiments on a total of 1817 probes,
which include an additional set of 603 probes. Most of
these 603 probes were selected based on sub-optimal spe-
cificity thresholds to assess the effect of various specificity
criteria on cross hybridization. These 603 probes included
79 probes that were duplicated for verifying consistency of
hybridization intensities with individual probes.
Samples from five different strains, B. mallei ATCC 23344,
B. mallei NCTC 10229, B. pseudomallei K96243, B. pseu-
domallei 238, and B. thailandensis E264, were prepared for
hybridization by restriction digestion in a cocktail of five
restriction endonucleases: Rsa I, Hpa II, Hinp1 I, HpyCH4
IV, and Alu I (New England Biolabs, Ipswich, MA). Frag-
mented DNA was labeled with a ULYSIS 647 Nucleic Acid
Labeling Kit (Invitrogen, Carlsbad, CA), following the
manufacturer's instructions. One microgram of each
labeled DNA was hybridized onto one segment each of
three replicate custom Agilent 8x15K Comparative
Genomic Hybridization (CGH) microarray chips (Agilent
Technologies, Santa Clara, CA), following the manufac-
turer's instructions. Each CGH microarray chip consisted
of eight identical individual array segments, each with
15000 features. Each individual array segment contained
seven replicates each of the 1817 selected Burkholderia
probes and seven replicates each of 31 negative control
probes. The remaining unspecified features were popu-
lated by Agilent control probes, which were not included
in the analysis. Hybridized chips were scanned with a
GenePix 4000B Axon Scanner, using GenePix Pro 6.1 soft-
ware (Molecular Devices, Sunnyvale, CA) at 5 μm for indi-
vidual spot evaluation.
Evaluation of experimental results
We analyzed the hybridization results using microarray
data analysis functions available in the MATLAB Bioinfor-
matics Toolbox http://www.mathworks.com. We normal-
ized the data among corresponding arrays in each of the
three chips using the quantile normalization method [25]
and logarithmically transformed the normalized hybridi-
zation intensities. Subsequently, we subtracted the back-
ground, which was estimated for each array on each chip
using the set of 31 negative control probes. The resulting
normalized values were used for evaluating the probes.
The complete list of 1817 probes and their normalized
hybridization intensities are given in Additional file 1.
Table 4 shows the median (mB) and standard deviation
(σ) of the estimated non-logarithmically transformed
background intensities. The background intensities were
very consistent across the three chips (not shown), as well
as among the three Burkholderia strains. Similar to probe
design, we used two empirical thresholds RL and RU to
classify probes based on these normalized hybridization
data. We selected the lower threshold RL to assess cross
hybridization with non-targets to be slightly less than 3σ
above the background (see Table 4), RL = 0.5. For the
upper threshold RU, which is used to assess hybridization
with the intended targets, we selected a very conservative
value of more than 6σ above the background, RU = 1.0.
To enable consistent comparison between probes
designed by TOFI and the experimental results, we re-eval-
uated the number of in silico fingerprints in a manner that
simulates the experimental setup, using the same design
thresholds CL and CU indicated in Table 2. Table 5 illus-
trates the different combinations of the three target
strains, B. mallei ATCC 23344, B. mallei NCTC 10229, and
B. pseudomallei K96243, that were available for experimen-
tal analysis. The first column denotes the five different
groups of probes or categories we compared, and the sec-
ond column identifies the number of re-evaluated in silico
(i.e., design) probes. Categories I, II and III correspond to
probes unique to individual targets, while treating all
other genomes as non-targets. Probes in category IV are
common to both B. mallei ATCC 23344 and B. mallei
NCTC 10229, considering all other genomes (including B.
pseudomallei K96243) as non-targets. Probes in Category V
Table 4: Background hybridization intensities averaged over three chips for three Burkholderia genomes
B. pseudomallei K96243 B. mallei ATCC 23344 B. mallei NCTC 10229
Median background intensity (mB) 3710 3076 3890
Standard deviation of background intensity (σ) 548 463 569
0.53 0.54 0.53
0.92 0.92 0.90
log2
3 mB
mB
RL + () ≈
σ
log2
6 mB
mB
RU + () ≈
σBMC Genomics 2008, 9:496 http://www.biomedcentral.com/1471-2164/9/496
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are common to all three target genomes, considering B.
thailandensis as the non-target.
Based on the experimental results, we classify the probes
in each category into three classes (Table 5). Class A corre-
sponds to probes that have normalized hybridization
intensity greater than RU with the intended targets and
normalized hybridization intensity less than or equal to
RL with non-targets. Class B designates probes that have
normalized hybridization intensity greater than RL with
non-targets, whereas Class C designates probes that have
normalized hybridization intensity less than or equal to
RU with the intended targets. Therefore, Class A probes are
the probes that behave as expected. Note that some probes
can be in both Class B and Class C, and that the purpose
of the design criteria CU and CL is to maximize the number
of probes in Class A and minimize the number of probes
in Class B and Class C.
Due to the high similarity between the two B. mallei
genomes, the probes in Categories I and II (both in silico
and experimental) are too few for analysis. According to
the design criteria, 523 probes out of the 1817 are unique
to B. pseudomallei (Category III). According to the experi-
mental thresholds, 420 (80%) of these are in Class A,
meaning that they hybridize with B. pseudomallei and do
not hybridize with any of the other genomes. Relatively
few probes in this category are in Class B or Class C. The
probes unique to both strains of B. mallei (Category IV)
perform similarly. A large fraction (81%) of these probes
is in Class A. The probes in Category V, which are expected
to hybridize with all three target genomes, behaved differ-
ently. Less than half of these probes (43%) are in Class A,
whereas the majority (55%) of these probes are in Class C,
meaning that they are failing to hybridize with some or all
of the intended targets.
Performance against an unsequenced target
The robustness of common probes designed to identify a
group of targets can be evaluated by testing their hybridi-
zation against another member of the group that was not
included in the design process. Accordingly, we obtained
the hybridization results of the 1817 probes with B. pseu-
domallei 238, for which the genome sequence is not avail-
able from NCBI. Hybridization results with this strain
might provide insights into how common probes
designed based on a limited set of strains of B. pseudomal-
lei and B. mallei would perform on unsequenced strains of
these pathogens. Table 6 shows the performance of these
group-specific probes as the result of hybridization exper-
iments with B. pseudomallei 238. The 302 in silico probes
in Category VI represent the subset of the 1817 probes
that are expected to identify all eight target genomes listed
in Table 1. Similarly, the 92 probes in Category VII are
expected to identify all four B. pseudomallei genomes in
Table 1.
Out of the 302 probes in Category VI, 236 (78%) have
normalized hybridization intensity greater than RU = 1.0
with B. pseudomallei 238 and less than RL = 0.5 with B. thai-
landensis E264. Similarly, out of the 92 B. pseudomallei-
specific probes in Category VII, 60 (65%) probes have
Table 5: Evaluation of in silico (design) probes against hybridization results with RU = 1.0 and RL = 0.5 for five categories of probes
Category (targets) In silico Experimental
Class A Class B Class C
I (B. mallei ATCC 23344) 0 0 (0%) 0 (0%) 0 (0%)
II (B. mallei NCTC 10229) 2 0 (0%) 2 (100%) 0 (0%)
III (B. pseudomallei K96243) 523 420 (80%) 53 (10%) 50 (10%)
IV (B. mallei ATCC 23344 and B. mallei NCTC 10229) 21 17 (81%) 2 (10%) 2 (10%)
V (B. mallei ATCC 23344, B. mallei NCTC 10229 and B. pseudomallei K96243) 431 184 (43%) 12 (3%) 236 (55%)
Probes that behave as expected are categorized as Class A; i.e., these probes have normalized hybridization intensity greater than RU with intended 
targets and less than RL with non-targets. Class B probes have normalized hybridization intensity greater than RL with non-targets, and Class C 
probes have normalized hybridization intensity less than RU with the intended targets.
Table 6: Experimental hybridization results of group-specific in silico probes tested against B. pseudomallei 238
Category (targets) In silico Probes hybridizing with B. pseudomallei 238
VI (B. mallei and B. pseudomallei) 302 236 (78%)
VII (B. pseudomallei specific) 92 60 (65%)BMC Genomics 2008, 9:496 http://www.biomedcentral.com/1471-2164/9/496
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normalized hybridization intensity greater than RU with
B. pseudomallei 238, and less than RL with the two strains
of B. mallei and the strain of B. thailandensis tested. These
results indicate that these group-specific probes can be
used to identify B. pseudomallei 238, and possibly other
unsequenced strains of B. mallei and B. pseudomallei.
Experimental inconsistencies
Based on the two design thresholds, CU and CL, all 431
probes in Category V are expected to hybridize to all three
targets. However, as shown in Table 5, only 184 of these
are in Class A, whereas many (236) are in Class C. To
understand why this might be happening, we looked at
the number of probes out of these 431 that hybridize to
each of the three individual targets. We found that 343
probes (80%) hybridized with B. mallei ATCC 23344, 408
probes (95%) hybridized with B. mallei NCTC 10229, and
only 196 probes (45%) hybridized with B. pseudomallei
K96243. This clearly indicates that most of the probes in
category V failed to hybridize with B. pseudomallei
K96243.
Further insights can be gained by looking at the probes
that have 100% identity with each of the three targets.
There are 382 such probes, and all of them are expected to
hybridize to all three targets. Figure 2 shows the histo-
grams of the normalized hybridization intensities for
these 382 probes. Figures 2a, 2b, and 2c indicate that
hybridization intensities with the B. mallei strains are sig-
nificantly higher than those with B. pseudomallei K96243.
The median hybridization intensities for both strains of B.
mallei are substantially above the experimental threshold
RU = 1.0, which is not the case for B. pseudomallei K96243.
Hybridization with the unsequenced strain B. pseudomallei
238 in Figure 2d is also comparable to that of the two B.
mallei strains, with a median value (1.61) higher than the
threshold (1.0), indicating that a large fraction of these
382 probes can be used to detect this strain. Hybridization
with B. thailandensis E264 (not shown) is at the back-
ground level.
Based on these histograms, one might be tempted to con-
clude that the hybridization intensities with B. pseudomal-
lei K96243 are lower than those for the remaining strains
due to some experimental anomaly. However, this does
not seem to be the case because most of the 523 probes in
category III (Table 5) that are expected to hybridize only
to  B. pseudomallei K96243 perform as expected. The
median hybridization for these 523 probes is 2.44, which
is well above the threshold 1.0. Currently, we do not have
an explanation for why the strain-specific probes are
hybridizing as expected with B. pseudomallei K96243,
whereas group-specific probes are failing. We are investi-
gating the causes for the observed discrepancies.
Conclusion
The enhanced TOFI pipeline can efficiently design micro-
array fingerprints for multiple, related bacterial and viral
genomes. We designed probes for eight pathogenic Bur-
kholderia genomes, covering probes unique to single tar-
gets as well as probes common to groups of targets. Probe
design results show that the presented method is effective
in taking advantage of the commonalities among the
genomes to considerably reduce the overall computation
time (about a four-fold reduction in this case, with larger
gains for larger number of input targets). This indicates
that the pipeline can be used to design fingerprints for a
large number of related microbial genomes in a single
run. In addition, the computational efficiency of the pipe-
line allows quick reevaluation of the probes as new target/
non-target sequences become available.
This study also allowed us to assess and experimentally
validate new specificity criteria recently introduced by
Vijaya Satya et al. [12]. Preliminary hybridization results,
with three targets, one unsequenced target, and one non-
target, demonstrate that only a small percentage of the
designed probes (≤10%) cross hybridize with non-targets
(last three rows of Class B in Table 5). However, addi-
tional tests with a larger panel of non-target genomes are
necessary to qualify the selected probes for diagnostic
Histograms of normalized hybridization intensities for the  382 probes that have 100% identity with the three target  genomes Figure 2
Histograms of normalized hybridization intensities 
for the 382 probes that have 100% identity with the 
three target genomes. The X-axis shows the normalized 
hybridization intensities and the Y-axis shows the number of 
probes that have a given normalized hybridization intensity. 
Many of the 382 probes fail to hybridize with B. pseudomallei 
K96243 even though all these probes have 100% identity 
with this genome, whereas hybridization intensities for the 
other three genomes are as expected.
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assays. More than 65% of the group-specific probes iden-
tify the unsequenced B. pseudomallei 238 strain, which
suggests that these probes might be useful in identifying
new strains of B. mallei or B. pseudomallei.
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